chloroquine and atovaquone

chloroquine has been researched along with atovaquone in 127 studies

Research

Studies (127)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (4.72)18.2507
2000's40 (31.50)29.6817
2010's67 (52.76)24.3611
2020's14 (11.02)2.80

Authors

AuthorsStudies
Alzeer, J; Chollet, J; Heinze-Krauss, I; Hubschwerlen, C; Matile, H; Ridley, RG1
Topliss, JG; Yoshida, F1
Jomaa, H; Mitsch, A; Schlitzer, M; Wiesner, J; Wissner, P1
Gochfeld, DJ; Hamann, MT1
Baniecki, ML; Clardy, J; Wirth, DF1
Benoit-Vical, F; Berry, A; Cazelles, J; Dechy-Cabaret, O; Deymier, C; Lelièvre, J; Loup, C; Magnaval, JF; Meunier, B; Robert, A1
Batchelor, JF; Bueno, JM; Capon, EC; Cheesman, NJ; Chicharro, J; Fernández, E; Fiandor, JM; Fry, M; Gargallo-Viola, D; Gómez de las Heras, F; Herreros, E; Hudson, AT; León, ML; Pudney, M; Trimming, H; Woolven, J; Yeates, CL1
Lombardo, F; Obach, RS; Waters, NJ1
Almeras, L; Amalvict, R; Baret, E; Briolant, S; Fusaï, T; Henry, M; Parquet, V; Pradines, B; Rogier, C; Torrentino-Madamet, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Carrasco, M; dos Santos, DJ; Guedes, RC; Gut, J; Lopes, F; Moreira, R; Rodrigues, T; Rosenthal, PJ1
Ane, M; Baziard-Mouysset, G; El Hage, S; Marjorie, M; Payard, M; Stigliani, JL; Vial, H1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Biagini, GA; Chandramohanadas, R; Darling, C; DeGrado, WF; Diamond, SL; Fisher, N; Greenbaum, DC; Jing, H; Jo, H; Lucumi, E; Napper, AD; Shone, AE; Ward, SA1
Beck, HP; Brun, R; Cohen, SB; Dartois, V; Dharia, NV; Diagana, TT; Fidock, DA; Goh, A; González-Páez, GE; Jegla, T; Keller, TH; Lakshminarayana, SB; Lee, MC; McNamara, C; Nosten, F; Plouffe, DM; Renia, L; Rottmann, M; Russell, B; Schmitt, EK; Seitz, P; Spencer, KR; Suwanarusk, R; Tan, J; Winzeler, EA; Yeung, BK; Zou, B1
Burrows, JN; Cross, RM; Kyle, DE; Manetsch, R; Monastyrskyi, A; Mutka, TS1
Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M1
Bathurst, I; Buckner, FS; Burrows, J; Charman, SA; Charman, WN; Creason, S; Deng, X; El Mazouni, F; Floyd, DM; Gujjar, R; Matthews, D; Phillips, MA; Rathod, PK; Shackleford, DM; White, J; White, KL1
Cross, RM; Kyle, DE; Luong, L; Maignan, JR; Manetsch, R; Mutka, TS; Sargent, J1
Davies, J; Gordey, EE; Gossage, RA; Merrin, MP; Sadowy, AL; Smith, TG; Ward, SA; Woodman, GM; Yadav, PN1
Cross, RM; Kyle, DE; Luong, L; Manetsch, R; Mutka, TS; Namelikonda, NK1
Amewu, R; Berger, O; Berry, NG; Biagini, GA; Charoensutthivarakul, S; Fisher, NE; Gibbons, P; Hill, A; Hong, WD; Leung, SC; Mbekeani, A; Nixon, GL; O'Neill, PM; Pacorel, B; Pidathala, C; Sharma, R; Shone, AE; Srivastava, A; Stocks, PA; Taylor, L; Ward, SA; Warman, AJ1
Docampo, R; Galizzi, M; Gut, J; Long, TE; Lu, X; Rosenthal, PJ1
da Rocha, DR; Ferreira, VF; Garcia, CR; Gaur, P; Santos, IO; Sharma, A1
Bronze, MR; da Cruz, FP; Gamo, FJ; Gonçalves, D; Gut, J; Lafuente-Monasterio, MJ; Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Ressurreição, AS; Rodrigues, T; Rosenthal, PJ; Schneider, G; Sitoe, AR1
Brannigan, JA; Holder, AA; Leatherbarrow, RJ; Meister, S; Rackham, MD; Rangachari, K; Tate, EW; Wilkinson, AJ1
Bathurst, I; Burrows, JN; Charman, SA; Doggett, JS; Forquer, IP; Hinrichs, DJ; Katneni, K; Kelly, JX; Li, Y; Mather, MW; Miley, GP; Nilsen, A; Pershing, AM; Pou, S; Riscoe, MK; Ryan, E; Stickles, AM; Vaidya, AB; White, KL; Winter, RW; Zakharov, LN1
Albuquerque, IS; Bronze, MR; Gonçalves, LM; Guedes, RC; Gut, J; Lopes, F; Meireles, P; Moreira, R; O'Neill, PM; Oliveira, R; Pires, E; Prudêncio, M; Rosenthal, PJ1
Andrews, KT; Avery, VM; Duffy, S; Hamacher, A; Hansen, FK; Kassack, MU; Kuna, K; Kurz, T; Marek, L; Meister, S; Mordmüller, B; Schmetter, R; Stenzel, K; Sumanadasa, SD; Winzeler, EA1
Angulo-Barturen, I; Avery, VM; Awasthy, D; Balasubramanian, V; Bandodkar, B; Barde, SP; Bharath, S; Chinnapattu, M; Duffy, S; Ferrer, S; Gamo, FJ; Hameed P, S; Hosagrahara, V; Iyer, PS; Jatheendranath, S; Jiménez-Díaz, MB; Kavanagh, S; Koushik, K; Lukens, AK; Magistrado, PA; Manjrekar, P; Martínez, MS; Morayya, S; Mukherjee, K; Narayan, C; Narayanan, S; Panduga, V; Patil, V; Prabhakar, KR; Raichurkar, A; Ramachandran, S; Rautela, N; Reddy, J; Rudrapatna, SS; Sambandamurthy, VK; Sanz, LM; Saralaya, R; Shanbag, G; Sinha, A; Srivastava, A; Viswanath, P; Waterson, D; Wirth, DF1
Altharawi, A; Gut, J; Long, TE; Lu, X; Rosenthal, PJ1
Achar, V; Angulo-Barturen, I; Avery, VM; Awasthy, D; Bharath, S; Coburn-Flynn, O; Duffy, S; Ferrer, S; Fidock, DA; Gamo, FJ; Hameed P, S; Hosagrahara, V; Iyer, PS; Jiménez-Díaz, MB; Kavanagh, S; Lee, MC; Martínez, MS; Menasinakai, S; Morayya, S; Nanduri, R; Narayanan, S; Panduga, V; Prabhakar, KR; Raichurkar, A; Ramachandran, S; Rautela, N; Reddy, J; Sambandamurthy, VK; Sanz, LM; Saralaya, R; Shanbhag, G; Srivastava, A; Waterson, D1
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L1
Chinnapattu, M; Iyer, PS; Sathiyanarayanan, KI1
Iyer, PS; Kannan, M; Khan, FR; Raichurkar, AV1
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P1
Bu, W; Campo, B; Ding, J; Easom, EE; Freund, YR; Gamo, FJ; Ge, M; Guo, D; Jacobs, RT; Li, L; Plattner, JJ; Rosenthal, PJ; Sanders, V; Sanz, LM; Yang, Y; Zhang, YK1
Chibale, K; de Kock, C; Kaur, H; Machado, M; Prudêncio, M; Singh, K; Smith, P1
Coelho, L; Lukens, AK; Mazitschek, R; Moreira, R; Nogueira, F; Paulo, A; Santos, SA; Wirth, DF1
Albuquerque, IS; Burojević, J; D'Alessandro, S; Djurković-Djaković, O; Konstantinović, J; Machado, M; Pecic, S; Prudêncio, M; Sciotti, RJ; Šolaja, BA; Srbljanović, J; Štajner, T; Taramelli, D; Terzić, N; Tot, M; Verbić, T; Zlatović, M1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Blake, LD; Burrows, JN; Casandra, D; Giarrusso, J; Kyle, DE; LaCrue, AN; Lichorowic, CL; Maignan, JR; Manetsch, R; Mutka, TS; Willis, PA1
Azas, N; Desroches, J; El-Kashef, H; Gellis, A; Hutter, S; Kieffer, C; Primas, N; Rathelot, P; Vanelle, P; Verhaeghe, P1
Campbell, S; Charman, SA; Chen, G; Dias, LC; Krake, SH; Martinez, PDG; McLaren, J; Ryan, E; White, K; Willis, P1
Berry, P; Campo, B; Cao, J; Ciaravino, V; Easom, EE; Erve, JCL; Freund, YR; Gamo, FJ; Guo, D; Jacobs, RT; Plattner, JJ; Rosenthal, PJ; Sanz, LM; Zhang, YK1
Avery, VM; Buchholz, M; Delves, MJ; Duffy, S; Fischli, C; Held, J; Knaab, TC; Kuna, K; Kurz, T; Lehmann, U; Leven, M; Lungerich, B; Meister, S; Meitzner, D; Mordmüller, B; Stahlke, P; Winzeler, EA; Wittlin, S1
Blake, LD; Burrows, JN; Casandra, D; Kyle, DE; LaCrue, AN; Lichorowic, CL; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Mutka, TS; Neelarapu, R; Willis, PA1
Arantes, LM; Braga de Oliveira, A; Brandão, GC; Doerksen, RJ; Pereira, GR; Rocha Missias, FC; Roy, KK; Soares, LF1
Aguiar, ACC; Correia, CRD; Costa, JL; de Souza, GE; Garcia, CRS; Garcia, ML; Guido, RVC; Nakabashi, M; Oliva, G; Panciera, M; Simão Dos Santos, EF; Singh, MK1
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA1
Amporndanai, K; Antonyuk, S; Berry, NG; Biagini, GA; David Hong, W; Davies, J; Leung, SC; Nixon, GL; O'Neill, PM; Priestley, RS; Samar Hasnain, S; Ward, SA1
Aguiar, ACC; de Souza, JO; Fagundez, C; Gamo, FJ; Guido, RVC; Ottilie, S; Peña, S; Sanz, LM; Scarone, L; Sellanes, D; Serra, GL; Stewart, L; Winzeler, EA; Yardley, V1
Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P1
Cheong, SL; Ng, CH; Tibon, NS1
Fontinha, D; Francisco, D; Mendes, AM; Prudêncio, M; Singh, K; Singh, L1
Bane, CE; Bayles, BR; Black, C; Butler, K; Caridha, D; Ceja, FG; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Mu, J; Nolan, C; Olmeda, R; Potter, B; Pou, S; Pybus, B; Rasmussen, SA; Read, L; Reynolds, KA; Riscoe, MK; Roncal, N; Rosenthal, PJ; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Tumwebaze, PK; Vesely, B; Vuong, C; Xie, L; Zeng, Q; Zhang, J; Zhang, P1
Arshadi, AK; Banks, R; Boonhok, R; Chakrabarti, D; Collins, J; Huang, G; Melendez, J; Miao, J; Min, H; Murillo Solano, C; Shaw, J; Yuan, Y1
Boonhok, R; Chakrabarti, D; Huang, G; Melendez, J; Miao, J; Min, H; Solano, CM; Yu-Alfonzo, S; Yuan, Y1
Beteck, RM; Legoabe, LJ; Patel, OPS1
Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A1
Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M1
Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y1
Amanzougaghene, N; Amrane, D; Arnold, CS; Azas, N; Azqueta, A; Botté, C; Hutter, S; Louis, B; Mazier, D; Primas, N; Sanz-Serrano, J; Tajeri, S; Vanelle, P; Verhaeghe, P1
Akao, Y; Avery, VM; Charman, SA; Chen, G; Chen, X; Chiu, FCK; Cho, N; Crespo, B; Dechering, KJ; Duffy, S; Kamaura, M; Katneni, K; Laleu, B; Lucantoni, L; Ochida, A; Sanz, LM; Shackleford, DM; Sturm, A; Wang, B; White, KL; Wittlin, S1
Fourcade, L; Touze, JE1
Davis, TM1
Whitty, CJ1
Bustos, DG; Canete-Miguel, E; Canfield, CJ; Hutchinson, DB1
White, N1
Watt, G1
Dragsted, UB; Lundgren, JD1
Nosten, F1
Camus, D; Chulay, JD; Clarke, PD; Günther, M; Høgh, B; Joubert, I; Kain, KC; Nothdurft, HD; Overbosch, D; Roskell, NS; Shaw, D1
Kain, KC; Keystone, JS; Shanks, GD1
Beck, B; Blum, J; Funk, M; Furrer, H; Genton, B; Hatz, FR; Holzer, B; Loutan, L; Markwalder, K; Raeber, PA; Schlagenhauf, P; Siegl, G; Steffen, R; Stürchler, D; Wyss, R1
Campos, P; Canfield, CJ; Clendenes, M; Hutchinson, DB; Llanos-Cuentas, A1
World, MJ1
Jong, EC; Nothdurft, HD1
Barrett, PH; Davis, TM; Ilett, KF; Syed, DA1
Fischer, PR; Stauffer, W1
Chambers, JA1
Camus, D; De Boever, EH; Djossou, F; Dutoit, E; Hedgley, C; Høgh, B; Malvy, D; Miller, GB; Roskell, NS; Schilthuis, HJ1
Stingl, P1
Croft, AM3
Petersen, JE1
Kurtzhals, JA; Vestergaard, LS1
Bourée, P1
Berzins, K; Grandien, A; Hagstedt, M; Nyakeriga, AM; Perlmann, H; Perlmann, P; Troye-Blomberg, M; Zhivotovsky, B1
Deharo, E; Garavito, G; Maurel, S; Monje, MC; Nepveu, F; Valentin, A1
Abreu-Acosta, N; Foronda, P; Lorenzo-Morales, J; Orós, J; Ortega-Rivas, A; Santana-Morales, MA; Valladares, B1
Hyde, JE1
Meshnick, SR; Purfield, AE; Tidwell, RR1
Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B1
bin Reza, F; Chiodini, PL; Doherty, JF; Fifer, H; Gothard, P; Haustein, T; Nicholas, M; Njimgye-Tekumafor, NE; Pearce, RJ; Polley, SD; Sutherland, CJ1
Croft, AM; Jacquerioz, FA2
Gan, LS; Loh, JP1
Blair, S; Deharo, E; Pabón, A1
Terlouw, DJ; van Eijk, AM1
Bautista, JM; Diez, A; García-Granados, A; Marín-García, P; Moneriz, C; Puyet, A1
Congpuong, K; Sirichaisinthop, J; Treiber, M; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, U1
Ensom, MH; Wilby, KJ1
Bozzo, P; Einarson, A; Irvine, MH1
Fadden, SJ; Keene, DD; Roughton, S; Tong, JL1
Petersen, E; Schlagenhauf, P1
Dzinjalamala, FK; Laufer, MK; Laurens, MB; Masonga, R; Nyirenda, OM; Plowe, CV; Stokes-Riner, A; Taylor, TE; Thesing, PC1
Davioud-Charvet, E; Deponte, M; Ehrhardt, K; Ke, H; Lanzer, M; Vaidya, AB1
Kain, KC1
David, K; Møller, CH1
Combrinck, JM; Egan, TJ; Fong, KY; Gibhard, L; Smith, PJ; Wright, DW1
Chua, HH; Cobbold, SA; Creek, DJ; McConville, MJ; Nijagal, B; Ralph, SA1
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA1
Deakin, J; Idris-Usman, M; Matthews, H; Nirmalan, NJ; Rajab, M1
Banura, P; Guler, JL; Houpt, E; Huang, F; Jacob, ST; Laufer, MK; Liu, J; Moore, CC; Pholwat, S; Stroup, S1
Almela, MJ; Angulo-Barturen, Í; Bamborough, P; Burrows, J; Calderón, F; Cammack, N; Castañeda, P; Chaparro, MJ; Coterón, JM; Crespo, B; de Cozar, C; de la Rosa, JC; de Mercado, J; Díaz, B; Drewes, G; Fernández, E; Ferrer-Bazaga, S; Fraile, MT; Gamo, FJ; Ghidelli-Disse, S; Gómez, R; Haselden, J; Huss, S; Jiménez Díaz, MB; Lafuente-Monasterio, MJ; León, ML; Macdonald, SJF; Martín Hernando, JI; Martínez-Martínez, MS; Prats, S; Puente, M; Rodríguez, A; Rueda, L; Sandoval, E; Selenski, C; Vidal, J; Willis, P; Wilson, DM; Witty, M1
Hai, F; Islam, S1
Maayan, N; Pace, C; Saunders, R; Sinclair, D; Tickell-Painter, M1
Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K1
Fairley, JK; Gutman, JR; Tan, KR; Wang, M1
Jiang, TL; Li, CH; Tang, T1
Horii, T; Tougan, T; Toya, Y; Uchihashi, K1
Brett-Major, D; Fraser, J; Hickey, PW; Mitra, I; Riddle, MS; Tribble, DR1
Abichabki, NLM; Abreu-Filho, PG; Baroni, L; Brochi, JCV; de Luca, G; Pereira, LM; Yatsuda, AP1
Boelle, PY; Jauréguiberry, S; Kendjo, E; Le Goff, M; Piarroux, R; Thellier, M1

Reviews

21 review(s) available for chloroquine and atovaquone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
    European journal of medicinal chemistry, 2020, Feb-15, Volume: 188

    Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines

2020
Antimalarial application of quinones: A recent update.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Antimalarials; Dose-Response Relationship, Drug; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinones; Structure-Activity Relationship

2021
[Malarone: newcomer in the treatment of malaria].
    Medecine tropicale : revue du Corps de sante colonial, 1997, Volume: 57, Issue:3

    Topics: Antimalarials; Atovaquone; Chloroquine; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Resistance; Drug Tolerance; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil

1997
[Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Ugeskrift for laeger, 2000, Jul-31, Volume: 162, Issue:31

    Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil

2000
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jul-15, Volume: 33, Issue:2

    Topics: Animals; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Resistance; Health Planning Guidelines; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Primaquine; Proguanil

2001
[Malaria--chemoprophylaxis 2001].
    Therapeutische Umschau. Revue therapeutique, 2001, Volume: 58, Issue:6

    Topics: Africa; Antimalarials; Asia; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Proguanil; South America; Switzerland; Travel

2001
Current drugs for antimalarial chemoprophylaxis: a review of efficacy and safety.
    Journal of travel medicine, 2001, Volume: 8, Issue:Suppl 3

    Topics: Antimalarials; Atovaquone; Chloroquine; Doxycycline; Humans; Malaria; Mefloquine; Naphthoquinones; Primaquine; Proguanil

2001
Military aviators, special operations forces, and causal malaria prophylaxis.
    Military medicine, 2003, Volume: 168, Issue:12

    Topics: Aminoquinolines; Antimalarials; Atovaquone; Aviation; Chloroquine; Doxycycline; Drug Combinations; Humans; Malaria; Mefloquine; Military Personnel; Naphthoquinones; Primaquine; Proguanil; United States

2003
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices].
    MMW Fortschritte der Medizin, 2004, Jun-17, Volume: 146, Issue:25

    Topics: Adult; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Climate; Doxycycline; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Mefloquine; Naphthoquinones; Pregnancy; Proguanil; Risk Factors; Self Medication; Sesquiterpenes; Time Factors; Travel

2004
Malaria: prevention in travellers.
    Clinical evidence, 2003, Issue:10

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel

2003
Malaria: prevention in travellers.
    Clinical evidence, 2004, Issue:11

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel

2004
Malaria: prevention in travellers.
    Clinical evidence, 2004, Issue:12

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Travel

2004
[Malaria chemoprophylaxis].
    Ugeskrift for laeger, 2005, Oct-17, Volume: 167, Issue:42

    Topics: Antimalarials; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Pregnancy; Proguanil; Risk Assessment; Travel

2005
Drug-resistant malaria - an insight.
    The FEBS journal, 2007, Volume: 274, Issue:18

    Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Folic Acid Antagonists; Humans; Malaria

2007
Drugs for preventing malaria in travellers.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel

2009
Azithromycin for treating uncomplicated malaria.
    The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure

2011
Pharmacokinetics of antimalarials in pregnancy: a systematic review.
    Clinical pharmacokinetics, 2011, Nov-01, Volume: 50, Issue:11

    Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Sulfadoxine

2011
WITHDRAWN: Drugs for preventing malaria in travellers.
    The Cochrane database of systematic reviews, 2015, Oct-05, Issue:10

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel

2015
Mefloquine for preventing malaria during travel to endemic areas.
    The Cochrane database of systematic reviews, 2017, 10-30, Volume: 10

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Primaquine; Proguanil; Randomized Controlled Trials as Topic; Travel-Related Illness

2017
[Research progress on heme metabolism in intraerythrocytic plasmodium].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2018, Volume: 43, Issue:18

    Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Erythrocytes; Heme; Hemoglobins; Humans; Plasmodium

2018

Trials

5 trial(s) available for chloroquine and atovaquone

ArticleYear
Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:6

    Topics: Antimalarials; Atovaquone; Chloroquine; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Malaria, Falciparum; Naphthoquinones; Philippines; Proguanil; Pyrimethamine; Sulfadoxine

1999
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Lancet (London, England), 2000, Dec-02, Volume: 356, Issue:9245

    Topics: Adolescent; Adult; Aged; Antimalarials; Anxiety; Atovaquone; Chloroquine; Dizziness; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Proguanil; Travel; Treatment Outcome

2000
Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2001, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Middle Aged; Naphthoquinones; Peru; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Outcome

2001
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-15, Volume: 38, Issue:12

    Topics: Adolescent; Antimalarials; Atovaquone; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Humans; Infant; Malaria; Naphthoquinones; Patient Compliance; Proguanil; Travel

2004
A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Antimalarials; Artemisinins; Artesunate; Atovaquone; Azithromycin; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endpoint Determination; Female; Genotyping Techniques; Humans; Infant; Longitudinal Studies; Malaria; Male; Proguanil

2012

Other Studies

101 other study(ies) available for chloroquine and atovaquone

ArticleYear
Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Acrylates; Administration, Cutaneous; Administration, Oral; Animals; Antimalarials; Benzene Derivatives; Erythrocytes; In Vitro Techniques; Malaria; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship

2000
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives.
    Bioorganic & medicinal chemistry letters, 2001, Feb-12, Volume: 11, Issue:3

    Topics: Animals; Antimalarials; Cinnamates; Combinatorial Chemistry Techniques; Inhibitory Concentration 50; Microbial Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship

2001
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp.
    Journal of natural products, 2001, Volume: 64, Issue:11

    Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured

2001
High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Animals; Biological Assay; Child, Preschool; DNA, Protozoan; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Female; Humans; Indoles; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy

2007
Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Aminoquinolines; Animals; Antimalarials; Erythrocytes; Mice; Plasmodium falciparum

2007
Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
    Journal of medicinal chemistry, 2008, May-08, Volume: 51, Issue:9

    Topics: Animals; Antimalarials; Malaria; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium yoelii; Pyridones; Structure-Activity Relationship

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Animals; Antimalarials; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plasmodium falciparum; Pyrroles

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials.
    Bioorganic & medicinal chemistry letters, 2009, Jul-01, Volume: 19, Issue:13

    Topics: Amines; Animals; Antimalarials; Computer Simulation; Drug Design; Drug Resistance; Electron Transport Complex III; Plasmodium falciparum; Pyridines; Structure-Activity Relationship

2009
Synthesis and antimalarial activity of new atovaquone derivatives.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Antimalarials; Atovaquone; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Animals; Antimalarials; Drug Resistance, Multiple; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum

2010
Spiroindolones, a potent compound class for the treatment of malaria.
    Science (New York, N.Y.), 2010, Sep-03, Volume: 329, Issue:5996

    Topics: Adenosine Triphosphatases; Animals; Antimalarials; Cell Line; Drug Discovery; Drug Resistance; Erythrocytes; Female; Genes, Protozoan; Humans; Indoles; Malaria; Male; Mice; Models, Molecular; Mutant Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Protein Synthesis Inhibitors; Protozoan Proteins; Rats; Rats, Wistar; Spiro Compounds

2010
Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
    Journal of medicinal chemistry, 2010, Oct-14, Volume: 53, Issue:19

    Topics: Antimalarials; Atovaquone; Drug Resistance; Drug Stability; Erythrocytes; Humans; Hydroxyquinolines; In Vitro Techniques; Microsomes, Liver; Parasitic Sensitivity Tests; Permeability; Plasmodium falciparum; Quinolones; Solubility; Stereoisomerism; Structure-Activity Relationship

2010
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
    Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

    Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins

2010
Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.
    Journal of medicinal chemistry, 2011, Jun-09, Volume: 54, Issue:11

    Topics: Animals; Antimalarials; Dihydroorotate Dehydrogenase; Disease Models, Animal; Drug Design; Drug Discovery; Enzyme Inhibitors; Humans; Malaria; Mice; Microsomes, Liver; Molecular Structure; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium berghei; Plasmodium falciparum; Protein Binding; Pyrimidines; Solubility; Structure-Activity Relationship; Triazoles

2011
Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships.
    Journal of medicinal chemistry, 2011, Jul-14, Volume: 54, Issue:13

    Topics: Acridines; Animals; Antimalarials; Cell Line; Drug Resistance; Erythrocytes; Humans; In Vitro Techniques; Mice; Microsomes, Liver; Plasmodium falciparum; Solubility; Structure-Activity Relationship

2011
Synthesis and biological activities of 4-N-(anilinyl-n-[oxazolyl])-7-chloroquinolines (n=3' or 4') against Plasmodium falciparum in in vitro models.
    Bioorganic & medicinal chemistry letters, 2011, Aug-01, Volume: 21, Issue:15

    Topics: Antimalarials; Chloroquine; Models, Biological; Oxazoles; Plasmodium falciparum; Quinolines

2011
Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones.
    Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24

    Topics: Animals; Antimalarials; Atovaquone; Cell Line; Drug Resistance; Mice; Plasmodium falciparum; Quinolones; Structure-Activity Relationship

2011
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
    Journal of medicinal chemistry, 2012, Mar-08, Volume: 55, Issue:5

    Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Crystallography, X-Ray; Cytochromes b; Drug Design; Drug Resistance; Humans; Malaria; Male; Mice; Microsomes, Liver; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyridines; Quinolones; Quinone Reductases; Rats; Structure-Activity Relationship

2012
Phosphonium lipocations as antiparasitic agents.
    Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8

    Topics: Animals; Antiparasitic Agents; Cations; Chagas Disease; Chlorocebus aethiops; Humans; Inhibitory Concentration 50; Lipids; Models, Biological; Organophosphorus Compounds; Plasmodium falciparum; Trypanosoma cruzi; Ubiquinone; Vero Cells

2012
Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl[1,4]naphthoquinones and their activity against the human malaria parasite Plasmodium falciparum (3D7).
    European journal of medicinal chemistry, 2013, Volume: 59

    Topics: Antimalarials; Cells, Cultured; Flow Cytometry; Humans; Indolequinones; Malaria, Falciparum; Molecular Structure; Naphthoquinones; Plasmodium falciparum; Sulfhydryl Compounds

2013
Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
    Journal of medicinal chemistry, 2013, Jun-13, Volume: 56, Issue:11

    Topics: Antimalarials; Cell Line, Tumor; Humans; Imines; Liver; Malaria; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship

2013
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).
    Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6

    Topics: Acyltransferases; Animals; Antimalarials; Blood; Chloroquine; Crystallography, X-Ray; Drug Design; Drug Resistance; Humans; Hydrogen Bonding; Indicators and Reagents; Ligands; Lipids; Liver; Mice; Models, Molecular; Molecular Conformation; Plasmodium falciparum; Plasmodium vivax; Structure-Activity Relationship; Thiophenes

2014
Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Animals; Antimalarials; Drug Discovery; HEK293 Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Plasmodium falciparum; Quinolones; Rats; Spectrometry, Mass, Electrospray Ionization

2014
Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Antimalarials; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Malaria; Mice, Inbred C57BL; Molecular Docking Simulation; Nitriles; Oxidative Stress; Peptidomimetics; Plasmodium berghei; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Tetraoxanes

2014
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
    European journal of medicinal chemistry, 2014, Jul-23, Volume: 82

    Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Discovery; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Repressor Proteins; Structure-Activity Relationship

2014
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
    Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13

    Topics: Animals; Antimalarials; Benzimidazoles; Biological Availability; Cell Line, Tumor; Cell Survival; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mice; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship

2014
1,4-naphthoquinone cations as antiplasmodial agents: hydroxy-, acyloxy-, and alkoxy-substituted analogues.
    ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12

    Topics:

2012
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
    Journal of medicinal chemistry, 2014, Aug-14, Volume: 57, Issue:15

    Topics: Aminopyridines; Animals; Antimalarials; Benzimidazoles; Hepatocytes; Humans; Malaria; Mice, SCID; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship

2014
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
    Journal of medicinal chemistry, 2014, Nov-13, Volume: 57, Issue:21

    Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship

2014
Synthesis and biological evaluation of adamantane-based aminophenols as a novel class of antiplasmodial agents.
    Bioorganic & medicinal chemistry letters, 2015, Feb-15, Volume: 25, Issue:4

    Topics: Adamantane; Aminophenols; Animals; Antimalarials; Cell Line; Humans; Plasmodium falciparum

2015
Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
    Bioorganic & medicinal chemistry letters, 2015, Mar-01, Volume: 25, Issue:5

    Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Molecular Docking Simulation; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Pyrimidines; Structure-Activity Relationship

2015
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
    European journal of medicinal chemistry, 2015, May-05, Volume: 95

    Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites

2015
Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
    Journal of medicinal chemistry, 2015, Jul-09, Volume: 58, Issue:13

    Topics: Animals; Antimalarials; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Survival; Female; Humans; Jurkat Cells; Malaria, Falciparum; Mice; Microsomes, Liver; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazines; Structure-Activity Relationship

2015
Primaquine-pyrimidine hybrids: synthesis and dual-stage antiplasmodial activity.
    European journal of medicinal chemistry, 2015, Aug-28, Volume: 101

    Topics: Animals; Antimalarials; Cell Line; Dose-Response Relationship, Drug; Humans; Liver; Mice; Mice, Inbred C57BL; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Primaquine; Pyrimidines; Structure-Activity Relationship

2015
Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype.
    European journal of medicinal chemistry, 2015, Sep-18, Volume: 102

    Topics: Antimalarials; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Indoles; Malaria; Molecular Structure; Niacinamide; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship

2015
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
    Journal of medicinal chemistry, 2016, Jan-14, Volume: 59, Issue:1

    Topics: Aminoquinolines; Animals; Antimalarials; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Hemin; Hepatocytes; Humans; In Vitro Techniques; Liver; Mice; Microsomes, Liver; Parasite Load; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes

2016
ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity.
    Journal of medicinal chemistry, 2016, 07-28, Volume: 59, Issue:14

    Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Quinolones; Structure-Activity Relationship

2016
Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold.
    European journal of medicinal chemistry, 2017, Jan-05, Volume: 125

    Topics: Antimalarials; Cell Survival; Drug Discovery; Hep G2 Cells; Humans; Plasmodium falciparum; Quinazolines; Sensitivity and Specificity; Structure-Activity Relationship

2017
Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans.
    European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

    Topics: Amines; Animals; Antimalarials; Drug Design; Drug Stability; Furans; Half-Life; Humans; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Structure-Activity Relationship

2017
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
    Journal of medicinal chemistry, 2017, 07-13, Volume: 60, Issue:13

    Topics: Amides; Animals; Antimalarials; Boron Compounds; Dogs; Female; Humans; Malaria; Malaria, Falciparum; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2017
3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.
    Journal of medicinal chemistry, 2017, 07-27, Volume: 60, Issue:14

    Topics: Amides; Animals; Antimalarials; Hep G2 Cells; Humans; Hydrazones; Malaria; Mice; Phenanthrenes; Plasmodium berghei; Stereoisomerism; Structure-Activity Relationship

2017
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
    Journal of medicinal chemistry, 2018, 02-22, Volume: 61, Issue:4

    Topics: Animals; Antimalarials; Drug Design; Humans; Mice; Piperazine; Plasmodium falciparum; Quinolones; Solubility; Structure-Activity Relationship

2018
Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds.
    European journal of medicinal chemistry, 2018, Feb-10, Volume: 145

    Topics: Antimalarials; Cell Survival; Chloroquine; Click Chemistry; Dose-Response Relationship, Drug; Drug Resistance; Hep G2 Cells; Humans; Models, Molecular; Molecular Structure; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship

2018
Discovery of Marinoquinolines as Potent and Fast-Acting Plasmodium falciparum Inhibitors with in Vivo Activity.
    Journal of medicinal chemistry, 2018, 07-12, Volume: 61, Issue:13

    Topics: Animals; Antimalarials; Drug Design; Mice; Models, Molecular; Molecular Conformation; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quinolines

2018
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins

2018
Potent Antimalarial 2-Pyrazolyl Quinolone
    ACS medicinal chemistry letters, 2018, Dec-13, Volume: 9, Issue:12

    Topics:

2018
Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing
    ACS medicinal chemistry letters, 2019, Jan-10, Volume: 10, Issue:1

    Topics:

2019
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
    Journal of medicinal chemistry, 2019, 04-11, Volume: 62, Issue:7

    Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship

2019
Molecular Design and Synthesis of Ivermectin Hybrids Targeting Hepatic and Erythrocytic Stages of
    Journal of medicinal chemistry, 2020, 02-27, Volume: 63, Issue:4

    Topics: Animals; Anopheles; Antimalarials; Binding Sites; Chloride Channels; Drug Design; Insecticides; Ivermectin; Molecular Docking Simulation; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Protein Binding; Structure-Activity Relationship

2020
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
    Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11

    Topics: Acridones; Administration, Oral; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Female; Half-Life; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred C57BL; Plasmodium falciparum; Structure-Activity Relationship

2020
Synthesis, Structure-Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines.
    Journal of medicinal chemistry, 2020, 10-22, Volume: 63, Issue:20

    Topics: Antimalarials; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship

2020
Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions.
    European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

    Topics: Antimalarials; Azides; Copper; Cycloaddition Reaction; Hep G2 Cells; Humans; Life Cycle Stages; Malaria, Falciparum; Plasmodium falciparum; Quinolines

2021
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
    Journal of medicinal chemistry, 2021, 03-11, Volume: 64, Issue:5

    Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles

2021
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
    Bioorganic & medicinal chemistry letters, 2021, 05-01, Volume: 39

    Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan

2021
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
    Journal of medicinal chemistry, 2021, 05-27, Volume: 64, Issue:10

    Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship

2021
Antiplasmodial 2-thiophenoxy-3-trichloromethyl quinoxalines target the apicoplast of Plasmodium falciparum.
    European journal of medicinal chemistry, 2021, Nov-15, Volume: 224

    Topics: Apicoplasts; Humans; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship

2021
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials.
    Journal of medicinal chemistry, 2021, 09-09, Volume: 64, Issue:17

    Topics: Administration, Oral; Animals; Antimalarials; Humans; Malaria, Falciparum; Mice; Molecular Structure; Plasmodium falciparum; Quinazolinones; Structure-Activity Relationship

2021
Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Risk Assessment

1998
Malaria prophylaxis for the 1990s and beyond.
    British journal of hospital medicine, 1997, Dec-10, Volume: 58, Issue:11

    Topics: Antimalarials; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Proguanil

1997
Antimalarial drug resistance and combination chemotherapy.
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 1999, Apr-29, Volume: 354, Issue:1384

    Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Sesquiterpenes

1999
Atovaquone-proguanil for falciparum malaria in the Philippines.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:1

    Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Philippines; Proguanil; Pyrimethamine; Sulfadoxine

2000
Prophylactic effect of Malarone against malaria: all good news?
    Lancet (London, England), 2000, Dec-02, Volume: 356, Issue:9245

    Topics: Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Naphthoquinones; Proguanil; Travel; Treatment Outcome

2000
Malaria remains a military medical problem.
    Journal of the Royal Army Medical Corps, 2001, Volume: 147, Issue:3

    Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Combinations; Global Health; Humans; Kenya; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Military Medicine; Military Personnel; Naphthoquinones; Patient Compliance; Plasmodium falciparum; Plasmodium vivax; Proguanil; Sierra Leone; Treatment Failure; Treatment Outcome; United Kingdom

2001
Toxicity related to chloroquine treatment of resistant vivax malaria.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4

    Topics: Adult; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Overdose; Humans; Malaria, Vivax; Male; Naphthoquinones; Plasmodium vivax; Primaquine; Proguanil

2003
Diagnosis and treatment of malaria in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Nov-15, Volume: 37, Issue:10

    Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine

2003
[Malaria prophylaxis for long-term travellers and expatriates].
    Ugeskrift for laeger, 2005, Oct-17, Volume: 167, Issue:42

    Topics: Antimalarials; Atovaquone; Chloroquine; Counseling; Doxycycline; Drug Combinations; Humans; Insect Bites and Stings; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Proguanil; Risk Assessment; Risk Factors; Travel

2005
[Malaria: a medical and economic problem].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:4 Pt 1

    Topics: Anti-Infective Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Naphthoquinones; Proguanil; Sesquiterpenes; Survival Rate; World Health Organization

2006
Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.
    Microbes and infection, 2006, Volume: 8, Issue:6

    Topics: Animals; Antimalarials; Apoptosis; Atovaquone; Cells, Cultured; Chloroquine; DNA Fragmentation; DNA, Protozoan; Enzyme Inhibitors; Erythrocytes; Etoposide; Flow Cytometry; Humans; In Situ Nick-End Labeling; Malaria, Falciparum; Membrane Potentials; Mitochondrial Membranes; Naphthoquinones; Nitric Oxide Donors; Parasitemia; Penicillamine; Plasmodium falciparum

2006
A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
    Experimental parasitology, 2007, Volume: 116, Issue:3

    Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Glutathione; Heme; Indicators and Reagents; Mefloquine; Methylene Blue; o-Phthalaldehyde; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Spectrometry, Fluorescence

2007
Clinical efficacy of antiparasite treatments against intestinal helminths and haematic protozoa in Gallotia caesaris (lizards).
    Experimental parasitology, 2007, Volume: 116, Issue:4

    Topics: Animals; Antiparasitic Agents; Atovaquone; Chloroquine; Drug Combinations; Feces; Fenbendazole; Helminthiasis, Animal; Intestinal Diseases, Parasitic; Lizards; Parasitemia; Pilot Projects; Proguanil; Protozoan Infections, Animal

2007
Interactions of DB75, a novel antimalarial agent, with other antimalarial drugs in vitro.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Animals; Antimalarials; Atovaquone; Benzamidines; Chloroquine; Drug Interactions; Parasitic Sensitivity Tests; Plasmodium falciparum

2008
In vitro and in vivo properties of ellagic acid in malaria treatment.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites

2009
Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Adult; Alleles; Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Chloroquine; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Haplotypes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; United Kingdom

2009
Rapid identification of chloroquine and atovaquone drug resistance in Plasmodium falciparum using high-resolution melt polymerase chain reaction.
    Malaria journal, 2010, May-21, Volume: 9

    Topics: Antimalarials; Atovaquone; Chloroquine; DNA, Protozoan; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Nucleic Acid Denaturation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sensitivity and Specificity

2010
Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs.
    Experimental parasitology, 2011, Volume: 127, Issue:1

    Topics: Amodiaquine; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Synergism; Erythrocytes; Flow Cytometry; Humans; Phytosterols; Plasmodium falciparum; Quinine; Solanum; Trophozoites

2011
Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages.
    Malaria journal, 2011, Apr-10, Volume: 10

    Topics: Antimalarials; Atovaquone; Chloroquine; Erythrocytes; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Triterpenes

2011
Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand.
    Wiener klinische Wochenschrift, 2011, Volume: 123 Suppl 1

    Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Lethal Dose 50; Mefloquine; Plasmodium vivax; Thailand

2011
Prophylactic use of antimalarials during pregnancy.
    Canadian family physician Medecin de famille canadien, 2011, Volume: 57, Issue:11

    Topics: Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Hydroxychloroquine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Travel

2011
Anti-malarial chemoprophylaxis following evacuation from Afghanistan.
    Journal of the Royal Army Medical Corps, 2012, Volume: 158, Issue:1

    Topics: Afghan Campaign 2001-; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Clinical Audit; Doxycycline; Drug Combinations; Drug Prescriptions; Humans; Malaria; Mefloquine; Military Personnel; Proguanil

2012
Standby emergency treatment of malaria in travelers: experience to date and new developments.
    Expert review of anti-infective therapy, 2012, Volume: 10, Issue:5

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Chloroquine; Diagnostic Tests, Routine; Drug Combinations; Emergency Treatment; Ethanolamines; Female; Fluorenes; Geography; Guidelines as Topic; Health Policy; Humans; Malaria; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Sensitivity and Specificity; Travel; Travel Medicine

2012
The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Antimalarials; Atovaquone; Chloroquine; Electron Transport; Erythrocytes; Humans; Inhibitory Concentration 50; Methylene Blue; Mitochondria; Oxidation-Reduction; Plasmodium falciparum; Structure-Activity Relationship; Vitamin K 3

2013
Prophylactic drugs for malaria: why do we need another one?
    Journal of travel medicine, 1999, Volume: 6 Suppl 1

    Topics: Adult; Antimalarials; Atovaquone; Chemoprevention; Child; Chloroquine; Developed Countries; Developing Countries; Drug Combinations; Female; Guidelines as Topic; Humans; Malaria; Male; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Risk Factors; Travel; Travel Medicine; Young Adult

1999
Imported malaria is stable from Africa but declining from Asia.
    Danish medical journal, 2014, Volume: 61, Issue:5

    Topics: Adolescent; Adult; Africa; Aged; Antimalarials; Asia; Atovaquone; Chemoprevention; Child; Child, Preschool; Chloroquine; Delayed Diagnosis; Denmark; Drug Combinations; Female; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Primaquine; Proguanil; Recurrence; Risk Factors; Severity of Illness Index; Travel; Young Adult

2014
Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials.
    Malaria journal, 2015, Jun-24, Volume: 14

    Topics: Amodiaquine; Antimalarials; Atovaquone; Chloroquine; Colorimetry; Heme; Plasmodium falciparum; Pyrimethamine; Trophozoites

2015
Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs.
    The Journal of infectious diseases, 2016, Jan-15, Volume: 213, Issue:2

    Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Fosfomycin; Gas Chromatography-Mass Spectrometry; Hemoglobins; Inhibitory Concentration 50; Methylene Blue; Naphthyridines; Plasmodium falciparum; Proguanil; Triazines

2016
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity

2016
Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Computational Biology; Drug Combinations; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Emetine; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil

2017
The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5

    Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Epidemiological Monitoring; Genotyping Techniques; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrimethamine; Reagent Kits, Diagnostic; Sulfadoxine

2017
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Topics: 2,2'-Dipyridyl; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Design; Female; Humans; Hydrazines; Mice; Mutagenicity Tests; Mutagens; Oxadiazoles; Parasitemia; Plasmodium falciparum; Pyrimethamine; Structure-Activity Relationship

2017
Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler.
    Paediatrics and international child health, 2018, Volume: 38, Issue:4

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Atovaquone; Chloroquine; Communicable Diseases, Imported; Drug Combinations; Emigrants and Immigrants; Humans; Infant; Liberia; Malaria; Male; Plasmodium malariae; Proguanil; Recurrence; Treatment Outcome; United States

2018
    The Indian journal of medical research, 2017, Volume: 146, Issue:5

    Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines

2017
A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.
    Malaria journal, 2018, May-15, Volume: 17, Issue:1

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Drug Combinations; Female; Humans; Live Birth; Mefloquine; Middle Aged; Pregnancy; Pregnancy Outcome; Premature Birth; Proguanil; Stillbirth; United States; Young Adult

2018
Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
    Malaria journal, 2019, Jan-14, Volume: 18, Issue:1

    Topics: Antimalarials; Atovaquone; Automation, Laboratory; Chloroquine; Drug Discovery; Hematology; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Schizonts; Trophozoites

2019
Deployment and Travel Medicine Knowledge, Attitudes, Practices, and Outcomes Study (KAPOS): Malaria Chemoprophylaxis Prescription Patterns in the Military Health System.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:1

    Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Military Medicine; Military Personnel; Practice Patterns, Physicians'; Primaquine; Proguanil; United States; Young Adult

2020
Atovaquone, chloroquine, primaquine, quinine and tetracycline: antiproliferative effects of relevant antimalarials on Neospora caninum.
    Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria, 2021, Volume: 30, Issue:1

    Topics: Antimalarials; Atovaquone; Chloroquine; Neospora; Primaquine; Quinine; Tetracyclines

2021
Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3

    Topics: Antimalarials; Atovaquone; Case-Control Studies; Chemoprevention; Chloroquine; Humans; Malaria; Malaria, Vivax; Plasmodium ovale; Plasmodium vivax; Travel

2023